- Home
- / Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Stock Price
$49.5
2024-10-29
Market Capitalization
$3 B
2024-10-29
Revenue
$189.8 M
FY, 2025
Rhythm Pharmaceuticals Summary
Company Summary
- Overview
- Rhythm Pharmaceuticals is a biopharmaceutical company. The Company is focused on the development and commercialization of peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders.
- Type
- Public
- Status
- Active
- Founded
- 2008
- HQ
- Boston, MA, US | view all locations
- Website
- http://www.rhythmtx.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Hunter Smith, Chief Financial Officer
Simon Kelner, Chief Human Resources Officer
Murray Stewart, Chief Medical Officer
LocationsView all
1 location detected
Boston, MA HQ
United States
222 Berkeley St # 12
Rhythm Pharmaceuticals Financials
Summary Financials
- Revenue (Q1, 2026)
- $60.1M
- Gross profit (Q1, 2026)
- $53.0M
- Net income (Q1, 2026)
- ($55.6M)
- Cash (Q1, 2026)
- $62.1M
- EBIT (Q1, 2026)
- ($52.4M)
- Enterprise value
- $3.1B